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T lymphocyte participation in antibody-induced experimental glomeru-
Ionephritis. Macrophage accumulation is a feature of some aggressive
forms of human and experimental glomerulonephritis (GN). Both
antibody Fc components and T cells may cause macrophage accumula-
tion; however, there has been no previous demonstration of T cells at
the site of injury in GN, although some indirect evidence of their
possible participation has been reported. Specific monoclonal anti-rat T
lymphocyte antibodies W3113, W3125, and 0x8 were used to demon-
strate T cells within the glomeruli of rats with an augmented autologous
anti-GBM GN, by indirect immunofluorescence. The injury in this
model has been shown to be mediated by macrophages. The T cell
infiltrate consisted mainly of T helper cells, was maximal 24 hr after
induction of the disease and clearly preceded the peak influx of
macrophages and glomerular damage. Suppression of T cell function
using cyclosporin prevented T cell accumulation and the subsequent
macrophage-induced injury. Glomerular T cells were not seen in
passively induced GN. These studies support a role for cell-mediated
immunity in attracting macrophages and initiating injury in experimen-
tal anti-GBM antibody-induced GN.
Participation lymphcytaire T a une glomerulonephrite expérimentale
induite par des anticorps. L'accumulation de macrophages est une
caractristique de certaines formes aggressives de glomerulonephrites
(GN) humaines et expérimentales. Les constituants Fc des anticorps et
les cellules T peuvent entrainer une accumulation macrophagique;
cependant, ii n'y a pas eu de demonstration antérieure de cellules T au
site de Ia lesion au cours des GN, bien que des preuves indirectes de
leur possible participation aient etC rapportées. Des anticorps
monoclonaux spCcifiques W3113, W3125, et 0x8 anti-lymphocytes T de
rat ant etC utilisés pour dCmontrer des cellules T dans les glomerules de
rats ayant une GN autologue anti-GBM accrue, par immunofluoresc-
ence indirecte. II a Cté montré que dans ce modèle, les lesions sont
mCdiCes par les macrophages. L'infiltrat de cellules T consistait essenti-
ellement en cellules T "helper," était maximum 24 heures après
l'induction de la maladie et précédait clairement Ic pic d'influx de
macrophages et les lesions glomerulaires, La suppression de Ia fonction
cellulaire T avec de Ia cyclosporin a prCvenu l'accumulation de cellules
T et les lesions ultCrieures induites par les macrophages. Des cellules T
glomCrulaires n'étaient pas observées dans des GN induites passive-
ment. Ces etudes sont en faveur d'un role de l'immunitC a mediation
cellulaire pour attirer les macrophages et initier des lesions dans une
GN experimentale induite par des anticorps anti-GBM.
Macrophages recently have been shown capable of producing
glomerular injury and proteinuria in both antiglomerular base-
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ment membrane (GBM) antibody and immune complex-induced
forms of experimental glomerulonephritis (ON) [1, 2]. Such
studies have given added significance to the observations of
participation of these cells in the more aggressive forms of
human GN [3—61. The mechanisms of glomerular macrophage
accumulation remain unclear. Supportive evidence of cell-
mediated immunity (CMI) involvement has come from the work
of Bhan et al [7, 8] who showed that transferred sensitized
lymphocytes were capable of inducing macrophage localization
within glomeruli. Other recent studies show that macrophages
can accumulate via non-antigen specific means through immune
adherence to the Fc portion of deposited disease inducing IgG
molecules [9].
The late phase of proteinuria observed in the autologous
phase of experimental rat anti-GBM antibody-induced GN has
been shown to be caused by macrophage accumulation [11. A
fundamental requirement of the evidence suggesting involve-
ment of CMI in experimental GN is to show that glomerular
lymphocyte accumulation does in fact occur in an accepted
active model of macrophage-induced ON. Further, if this mech-
anism has a functional role, the timing of lymphocyte accumula-
tion should clearly precede any macrophage ingress and should
be prevented by agents (for example, cyclosporin) known to
block T cell responses [10—12], The recent development of
specific monoclonal antibodies allows tissue identification of rat
T lymphocytes and their subpopulations [13—151.
Cyclosporin and monoclonal anti-T cell antibodies were used
in the current studies to assess the participation of T lympho-
cytes in a macrophage-dependent model of GN and to define
their relationship to macrophage accumulation within gb-
meruli.
Methods
Experimental anti-GBM glomerulonephritis
Heterologous (passive) and autobogous (active) models of
anti-GBM ON were studied. Anti-rat GBM antibody was pre-
pared by repeated immunization of a sheep with purified
particulate rat GBM in Freund's complete adjuvant (FCA) as
previously described [16]. The sheep serum was absorbed
extensively against rat serum and red cells and administered as
a globulin fraction, as previously described [2].
To induce heterobogous disease, a dose of 22 g globulin/g
body weight, shown to bind 85 g of kidney fixing antibody
(KFA)/g kidney (determined by binding studies using 1251 label-
530
T lymphocytes in experimental glomerulonephritis 531
led antibody) was administered intravenously to male Sprague-
Dawley rats. Glomerular injury was assessed at 24 hr. Autol-
ogous anti-GBM GN was induced by pre-immunization of rats
with sheep globulin (4 mg in 0.75 ml FCA, s.c.) followed 5 days
later by 22 sg globulin/g body weight (85 sg KFA/g kidney) of
the same sheep anti-rat GBM antibody.
Proteinuria. Rats were housed in metabolic cages to allow
collection of 24-hr urine samples. Protein concentrations were
determined by a turbidity assay [17]. Light transmission (541
nm wavelength) was measured using a light spectrophotometer
(Varian Techtron, Melbourne, Australia) 15 mm after the addi-
tion of three volumes of 3% sulpho-salicylic acid to one volume
of urine samples. Values were calculated from a standard curve
derived from bovine serum albumin (BSA) standards.
Histology. Kidney tissue samples were fixed in Bouin's
fixative and stained with periodic acid Schiff (PAS) reagent to
assess light microscopic appearances. Glomerular hypercel-
lularity was estimated by counting cell nuclei in equatorially
sectioned glomeruli. At least ten glomeruli per rat kidney were
counted.
Immunofluorescence microscopy. Tissue samples for im-
munofluorescence were frozen immediately in liquid nitrogen,
then stored at —70°C. Frozen sections (2 tm) were cut on a
cryostat and stained with monoclonal mouse anti-rat T cell
antibodies, clones W3/13, W3/25 and 0x8 (ascites fluid;
Seralab, Oxford, England). These clones have been previously
characterized: W3/13 is a pan-T cell marker [131, W3/25 stains
the T helper subset, and Ox8 stains the non-helper T cell subset
[14, 15]. After initial titering experiments these antibodies were
used at a dilution of 1:20, and the sections were subsequently
stained with fluoresceinated goat anti-mouse IgG, absorbed
with normal sheep IgG. Controls using the second antibody
alone, normal mouse sera and phosphate-buffered saline (PBS)
were performed. All T cell quantitation experiments were
conducted blind; the frozen tissue samples were number coded.
The results were obtained from three separate experiments and
represent overall means of the numbers of cells in ten glomeruli
on three separate occasions. In separate experiments, 100
glomeruli from known normal kidney tissue were examined to
determine the frequency of T cell accumulation, as revealed
with the monoclonal antibodies.
Electron microscopy. Tissue samples for transmission elec-
tron microscopy were fixed for 1 hr in Karnovsky's fixative.
After dehydration and embedding in Araldite resin, ultra-thin
sections were cut, stained with uranyl acetate and lead citrate,
and then viewed in an electron microscope (Siemens), at an
accelerating voltage of 75 kv.
Demonstration of macrophages. Two techniques were used
to demonstrate macrophage accumulation within glomeruli.
Frozen kidney tissue samples were cut into 8-sm sections and
stained for nonspecific esterase by the method of Yam, Li, and
Crosby [181. Staining was graded 0 to 4+, according to the area
of positive glomerular staining, to obtain a semiquantitative
estimate of the number of glomerular macrophages, as de-
scribed by Hunsicker et al [19]. Fifty glomeruli per rat kidney
were examined.
Glomerular macrophages were also quantitated by glomer-
ular cell culture [161. Glomeruli were isolated from aseptically
removed renal cortex and cultured individually in drops of
culture medium (Eagle's minimal essential medium, Flow Lab-
oratories, Melbourne, Australia) containing 10% fetal calf se-
rum (Flow Laboratories). After 4 days, macrophages in the
cellular outgrowths (previously identified by their light, phase,
cine, and electron microscopic appearances as well as their
histochemical profile, phagocytic behavior and presence of Fc
receptors [16]) were enumerated from at least 12 glomeruli per
rat and expressed as the mean number of macrophages per
glomerulus (macs/glom).
Quantitation of subsets of circulating T cells. Rats rep-
resentative of groups 1, 2, 3, and 5 had circulating total
mononuclear cells, total T cell, and T cell subsets quantitated in
standard fashion using a fluorescein (FITC) activated cell sorter
(FACS IV, Becton Dickinson), and the same monoclonal anti-T
cell reagents (Miss L. Bolger, Mr. R. McLean, and Drs. P. S.
Crosier and C. P. Swainson, Christchurch, New Zealand).
Measurements were made on day 1 in the experimental proto-
col, that is, 24-hr after anti-GBM antibody administration, using
a blind, coded protocol.
Experimental and control animals were bled by cardiac
puncture under light halothane anesthesia at 9:00 AM. The
peripheral blood leucocytes (PBL) from heparinized whole
blood were separated on a Ficoll-Hypaque density gradient
(cr1078) at room temperature. PBL (1 x 106) were incubated
with 5 ml of diluted monoclonal antibody and PBS to a total
volume of 200 ml in round-bottomed microtiter plates (Nunc)
for 30 mm on ice. The monoclonal antibodies (and working
dilutions) were W3/l3 (1:100), W3/25 (1:1000), and 0x8 (1:500).
All experiments were done with antibody from the same batch.
Following incubation the cells were washed twice in the ice-
cold PBS and then incubated with 100 l of a 1:40 dilution of
FITC-goat F(ab')2 anti-mouse [IgG and 1gM] antibody (Tago
Cat. No. 4343) for 30 mm on ice. After two further washes with
ice-cold PBS the cells were analyzed on the cell sorter using
forward and 90° light scatter to exclude cells and debris other
than lymphocytes. The results were expressed as a percentage
of positively labelled cells. The background count for negative
controls without monoclonal antibody was 0.2 to 0.6%. All cells
were analyzed in triplicate.
Rat anti-sheep globulin antibody. Titers of antibody to sheep
globulin were determined using passive hemagglutination of
tanned group 0 human red blood cells (RBCs) coated with
normal sheep globulin [201. Doubling dilutions of test and
normal sera were incubated with coated cells at a starting titer
of 1:10; the highest titer at which hemagglutination occurred
was noted. All sera were first absorbed against uncoated RBCs
and diluted 1 in 10 with PBS, Controls with uncoated cells and
test sera, and coated cells alone, were included.
Cyclosporin (CYS). It was generously supplied by Sandoz,
Base!, Switzerland, and prepared for parenteral administration
(100 sg/ml). All CYS-treated rats received a single daily dose of
25 mg/kg s.c. during the course of the experiment commencing
1 day prior to immunization.
Experimental design
Male Sprague-Dawley rats, weighing approximately 250 g,
were used throughout these experiments. Each group consisted
of six or seven animals. The following groups were studied
(Table 1):
Active anti-GBM GN (group 1). These animals were pre-
immunized with sheep globulin in FCA, injected with anti-GBM
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antibody 5 days later (day 0), and sacrificed on day I (group
1A), day 3 (group 1B), and day 5 (group 1C).
The effect of T cell suppression with CYS (group 2). The
effect of CYS on active anti-GBM GN was studied at the same
three time points as for group 1. Animals received daily CYS
(25 mg/kg) starting 1 day prior to pre-immunization and were
sacrificed on day 1 (group 2A), day 3 (group 2B), and day 5
(group 2C) following the initiation of the disease.
Control animals. Three different control groups were studied:
(1) normal rats (group 3), (2) heterologous anti-GBM GN
studied 24 hr after induction of the disease as previously
described (group 4), and (3) rats pre-immunized in the same way
as for the active disease, but injected 5 days later with normal
sheep globulin (22 sgIg body weight) in place of anti-GBM
antibody, and then sacrificed after 24 hr (day 1, group 5).
Results
Active anti-GBM GN (Fig. 1)
Histological appearances. Animals with autologous anti-
GBM GN developed an endocapillary proliferative lesion (Fig.
2A). Hypercellularity was also evident from glomerular cell
counts. Twenty-four hours after the injection of anti-GBM
antibody (group 1A), 59 1.5 SEM cells per glomerular cross-
section (c/gcs) were observed (normal 43.6 1.1 c/gcs, P <
0.01). Maximum proliferation was observed 3 days after anti-
GBM antibody (group 1B, 71.5 0.9 c/gcs), and remained
elevated on day 5 (group lC, 70.5 0.8 c/gcs).
Proteinuria. Abnormal proteinuria developed within 24 hr
after anti-GBM antibody administration (group lA, 90.7 14.3
mg/24 hr; normal 11.5 1.3 mg/24 hr, P <0.005), was maximal
after 3 days (group 1B, 242.6 37.9 mg/24 hr), and began to
decline after 5 days (group 1C, 203.6 54.1 mg/24 hr).
Antibody titers. All pre-immunized rats had significant titers
of anti-sheep globulin by day 1 (group 1A) 4.0 0,8 log2
hemagglutination titer rising to 7.9 0.6 log2 (group lB) on day
3 and 9.4 0.6 log2 (group 1C) on day 5.
Macrophage accumulation. Macrophage accumulation with-
in glomeruli as estimated by glomerular culture showed a
similar temporal pattern to the development of proteinuria: at
24 hr, 4.2 1.2 macs/glom (group 1A); day 3, 19.8 3.7
Table 1
Experimental groups
Group I. Autologous phase (active) anti-GMB GN
A Dayl 1
B Day 3 after anti-GBM antibody
C Day5
Group 2.
A
B
C
CYS-treated, autologous phase (active) anti-GBM GN
Dayl 1
Day 3 after anti-GBM antibody
DayS j
Control groups
Group 3. Normal rats
Group 4. Heterologous phase (passive) anti-GBM GN, 24 hr after
injection of heterologous anti-GBM antibody
Group 5. Pre-immunized with sheep globulin, injected with non-
immune sheep globulin and sacrificed 24 hr later
400
Proteinuria 200
mg/24 hr
Total glom 60
cells
c/gcs 30
Antibody titer 8
log2 4
2 W3/13Glom T-cells W 3/25
c/gcs 1 0X8p
20 +4
Macrophages Esterase
cells/glom 10 +2
Normal 1 3 5
rats
Days After Anti-GBM
antibody
Fig. 1. Development of proteinuria, glomerular hypercellularity, ant i-
sheep globulin antibody titers, and the appearance of glomerular T
cells and macrophages, on day 1 (group IA), day 3 (group IB), and day
5 (group IC) in autologous anti-GBM GN.
macs/glom (group 1B); and day 5, 12.4 6.2 macs/glom (group
1C, normals 0.1 0.01 macs/glom). The results of esterase
staining of macrophages within glomerli correlated with the
enumeration of macrophages in glomerular culture. Staining
was slight 24 hr after anti-GBM antibody (+ 1, group lA),
maximal on day 3 (+4, group 1B), and beginning to decline on
day 5 (+2, group lC). Normal tissues showed only very
occasional minor areas of esterase positive glomerular staining
(group 3).
Tcell accumulation. T cells could be distinguished clearly by
immunofluorescence using the specific, validated monoclonal
antibodies (Fig. 3). These appeared as brightly fluorescent
discrete circular areas without staining other tissue structures.
No positive cells were identifiable within any normal rat
glomeruli, using reagents W3/l3 and 0x8. Reagent W3/25
stained a mean of six cells in every 100 normal glomeruli
examined.
Electron microscopic studies confirmed the presence of cells
with the ultrastructural appearances of lymphocytes within
appropriate glomeruli (Fig. 4). Total T cell numbers (W3/13
monoclonal anti-T cell antibody staining) were maximal at 24 hr
after anti-GBM antibody (2.2 1.7 cells/gcs; group 1A) and
clearly preceded the peak appearance of macrophages which
occurred on day 3. On subsequent days, T cell numbers
declined (after 3 days, 1.4 0.8 cells/gcs group lB, and after 5
days, 0.4 0.5 cells/gcs group 1C). Examination for T cell
subsets indicated that the majority of infiltrating T cells within
nephritic glomeruli were T helper cells (W3/25, T helper cells
1.6 0.8 cells/gcs; 0x8, nonhelper subset 0.6 0.3 celllgcs; P
<0.05; Fig. 1).
The effect of T cell suppression (CYS) (Fig. 5)
Cyclosporin administration resulted in a marked attenuation
of the augmented autologous anti-GBM GN lesion.
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Fig. 3. A photomicrograph of a glomerulus from a rat with autologous
anti-GBM GN on day I (group IA) showing strong and discrete
immunofluorescence of a T cell stained with the monoclonal antibody
W3/13, and goat anti-mouse IgG F!TC. (original, x312)
Fig. 2. A The histological appearance of a glomerulus, showing diffuse
endocapillary glomerulonephritis on day 5 autologous anti-GBM GN.
(original magnification, x 135) B The appearance on the same day after
treatment with CYS showing considerable attenuation of the lesion.
(original, x 135)
Histological appearances. Glomerular hypercellularity was
evident after 24 hr, 59.0 1.7 c/gcs (group 2A), consistent with
the heterologous phase of injury; but then declined to 50.2
0.6 c/gcs on day 3 (group 2B), and 49.2 0.7 c/gcs on day 5
(group 2C). This was significantly less than observed in the
active disease, on days 3 and 5 (P < 0.01).
Proteinuria. After the heterologous phase of injury observed
on day 1 (protein excretion, group 2A, 74.4 18.1 mg/24 hr),
proteinuria subsided and was significantly less than proteinuria
observed in rats with untreated autologous disease (group 2B,
treated, 12.7 8.8 mg124 hr; group IB, untreated, 242.6 37.9
mg/24 hr, P < 0.005) and remained low on day 5 (group 2C,
treated 24.8 9.1 mg/24 hr; group 1C, untreated, 203.6 54.1
mg/24 hr, P < 0.005).
Antibody titers. Titers of anti-sheep globulin antibody were
significantly less in the CYS-treated rats, than those observed in
rats with active disease, on the 3 days studied (<1 log2, group
2A; <1 log2, group 2B; 4.4 1.0 log2, group 2C).
Macrophage accumulation. No significant macrophage influx
could be observed in rats treated with CYS, as assessed by
glomerular cell culture and esterase staining. Glomerular cell
Table 2. Comparison of disease parameters after 24 hr in
experimental and control groups
Proteinuria
mg124 hr
Antibody
titer
log2
Total
glomerular
cells
Experimental groups
Group 1A
(Autologous disease)
90.7 14.3 4.0 59.4 1.8
Group 2
(CYS-treated)
74.4 18.1 <1 59.3 0.7
Control groups
Group 3
(Normal rats)
11.5 1.3 <1 43.6 1.1
Group 4
(Heterologous disease)
108.3 18.6 <1 59.0 1.0
Group 5
(Normal sheep globulin)
10.5 1.3 2.5 45.5 0.6
culture results showed: 0.08 0.04 macs/glom, group 2A; 0
macs/glom, group 2B; 1.16 0.9 macs/glom, group 2C.
Tcell accumulation. Staining for T cells (using W3/13, W3125,
and 0x8 anti-T cell monoclonal antibodies) was negative in all
groups after CYS treatment. Using W3/13, all animals were
negative on days I and 3 (0 c/gcs, groups 2A and B) and one
animal, on day 5, showed an occasional glomerulus with a
single positive cell (group 2C, 0.02 0.04 c/gcs). Staining with
W3/25 in CYS-treated rats (groups 2 A to C) was not signifi-
cantly different from controls (group 3).
Heterologous anti-GBM GN (Tables 2 and 3)
Non-immunized rats injected with anti-GBM antibody devel-
oped an exudative GN (59.0 1.0 c/gcs) and proteinura (108.3
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Fig. 4. An electronphotomicrograph demonstrating the ultrastructural appearances of a glomeru/us from a rat with active anti-GBM GN on day
1 (group IA). The lumen of the capillary (Cap) contains lymphocytes (L); Ep represents epithelium. (original, X 2700)
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Fig. 5. The effect of CYS treatment on proteinuria, glomerular hypercel-
lularity, anti-sheep globulin antibody titers, and the appearance of T
cells and macrophages on day I (group 2A), day 3 (group 2B), and day
5 (group 2C) of autologous anti-GBM GN.
18.6 mg/24 hr, group 4) within 24 hr, as a result of deposition
of heterologous antibody. No T cells were identified within their
glomeruli by immunofluorescence and there was minimal
macrophage accumulation as assessed by glomerular culture
(0.6 0.2 macs/glom, group 1), or by esterase staining.
Pre-iminunized rats given normal sheep globulin (group 5)
(Tables 2 and 3)
Rats pre-immunized with sheep IgG in FCA did not develop
any glomerular injury 24 hr after the intravenous injection of
normal sheep globulin (group 5). There was no significant
proteinuria (10.5 1.3 mg/24 hr, group 5; 11.5 1.3 mg/24 hr,
group 3; normal control rats). There were no T cells demon-
strable within glomeruli in group 5 and insignificant numbers of
macrophages identified by glomerular culture (0.02 0.01
macs/glom) and esterase staining.
Quantitation of circulating T cell subsets (Table 4)
On day 1, pre-immunized rats developing untreated active
anti-GBM GN (group 1A) had significant increases in total
mononuclear cell, total T cell, and T cell subsets compared to
normal rats (group 3), P <0.005). Treatment with CYS (group
2A) resulted in a significant diminution of these effects, as well
as a significant alteration in the T cell subset ratios (T helper
cell/T non-helper cell = TH/Ts ratio = 1.27 group 2A, 1.17
group 3). Pre-immunized rats injected with normal sheep glob-
ulin (group 5) also developed significant increases in circulating
mononuclear cell, T cell, and T cell subset numbers compared
to normal rats (group 3), but this was not as marked as in the
rats developing active anti-GBM GN (group 1A). The T cell
200Proteinuria
mg/24 hr
Total glom
cells
c/gcs
Antibody titer
log2
Glom T-cells
c/gcs
Macrophages
cel/s/glom
- +4
+2
Esterase
'7
'C
q%
fl'
 '-'
M
 
I t1
'! 
A;
 r
 
4 
,
 - 
2:
 4 r .it.t4? 
T lymphocytes in experimental glomerulonephritis 535
Table 3. Comparison of glomerular T cells and macrophages after 24 hr in experimental and control groups
T cells
MacrophagesW3/13 W3/25 0x8
Experimental groups
Group 1A
(Autologous disease)
2.2 1.7 1.6 0.8 0.6 0.3 4.2 1.2
Group 2
(CYS-treated)
0 0.06 0.13 0 0.08 0.04
Control groups
Group 3
(Normal rats)
0 0.02 0.02 0 0.01 0.01
Group 4
(Heterologous disease)
0 0 0 0.06 0.02
Group 5
(Normal sheep globulin)
0 0.02 0.04 0.05 0.08 0.02 0.02
Table 4. Quantitation by FACS of circulating mononuclear cell, T cell, and T cell subsets after 24 hr in experimental and control groups
Experimental groups
Group IA
(Autologous disease)
18.0 2.1 9.5 1.1 6.7 0.9 1.42 32.3 3.3
Group 2
(CYS-treated)
Control groups
Group 3
(Normal rats)
Group 5
(Normal sheep globulin)
subset ratio in this group (group 5) was not significantly
different from normal rats.
Discussion
Macrophages have been shown to be a prominent infiltrating
cell population in aggressive forms of human GN [3—6]. Simi-
larly, macrophages are the predominant infiltrating leucocyte in
experimental models of proliferative and crescentic GN of both
anti-GBM [1, 2] and immune complex [2] pathogenesis. The
initial experiments showing a functional role for these cells in
inducing proteinuria were performed by Schreiner et al [11.
These investigators studied a pre-immunized model of anti-
GBM antibody-induced GN in the rat and demonstrated that the
injury in this model occurred in two phases and that the second
phase of injury depended on the accumulation of macrophages.
The current studies were performed in this same model.
The mechanisms of macrophage accumulation remain un-
clear. Accumulation may potentially be immune specific via
sensitized T lymphocytes and their products (cell-mediated
immunity, CMI) or through chemotactic mechanisms induced
by antibody deposition. Immune adherence via the Fc portion
of disease-initiating IgG molecules has been shown to be a
mechanism capable of producing macrophage accumulation [9].
The potential for CMI as a means of glomerular macrophage
localization has been shown by the transfer studies of Bhan et
a! [7, 81. However, in these studies lymphocytes were not
demonstrated in glomeruli nor was significant proteinuria in-
duced. Kreisberg, Wayne, and Karnovsky [211 demonstrated
that a transient influx of mononuclear cells with the electron
microscopic appearances of lymphocytes preceded macrophage
accumulation in experimental anti-GBM antibody-induced ON.
However, these observations were made immediately following
the injection of heterologous antibody to nonsensitized animals
where CMI would not be anticipated to be operative. Further
experiments assessing the role of T lymphocytes have been
undertaken in nude mice [22, 23]. Several authors have shown
that these animals are less susceptible to proliferative autoim-
mune GN. However, these experiments have failed to distin-
guish between the decreased B-cell response observed in these
animals and a reduced cell-mediated or T cell-directed compo-
nent of injury.
In the current studies we have shown that a T cell (pre-
dominantly T helper cell) influx is observed in an experimental
model of glomerular injury previously proven to be mediated by
T cells, x 1061m1 Total mononuclear
cells
TH/Ts xlO6ImlW3/l3 W3/25 0x8
6.3 0.6 3.3 0.3 2.6 0.3 1.27 10.1 1.1
5.1 0.6 2.7 0.3 2.3 0.4 1.17 7.9 1.1
8.2 1.1 4.6 0.5 3.7 0.6 1.23 11.9 1.5
536 Tipping et a!
macrophages [1]. T cells and their subsets have been demon-
strated with specific validated monoclonal antibodies, and cells
with the morphologic characteristics of lymphocytes were seen
by electron microscopy at the appropriate time point. The two
most widely accepted techniques (esterase staining and glomer-
ular cell culture) were used to demonstrate glomerular macro-
phages. The specificity of monoclonal anti-rat macrophage
antibodies is not uniformly accepted and therefore such re-
agents were not used as additional macrophage markers in these
investigations. In the model studied both B and T cell mecha-
nisms may contribute to macrophage accumulation as immu-
noglobulin is deposited at the time that T cells accumulate. The
timing of the glomerular localization of the effectors of the T
and B cell arms of the immune system favors a role for T cells
as their accumulation clearly precedes the peak of macrophage
ingress. Antibody production, however, continues to increase
as the macrophage presence wanes,
Recent studies of renal tissue samples from patients with GN
failed to identify a significant lymphocytic accumulation [24].
However, the current experimental studies may help place the
observations in human GN in perspective. These rat studies
show that T lymphocyte accumulation has resolved by the time
significant injury develops so that if this mechanism were
operative in human GN, it is probable that lymphocytes would
have disappeared by the time nephritis had developed and
diagnosis was made. The experimental disease examined was
an aggressive short-term model with injury developing within a
few days. In human GN, injury occurs over weeks, months, or
even years so that it is unlikely that the cellular immune
response within glomeruli demonstrable on renal biopsy would
be of the same intensity as that observed in this experimental
model. The observations from this rat model suggest that
lymphocyte accumulation would most likely be demonstrated
early in the course of fulminating acute forms of human GN.
CYS directly reduces T cell responses and potentially could
also indirectly affect B cells and macrophages; blocking experi-
ments using this agent would not then fully dissect the relative
importance of T cells and autologous antibody deposition in
disease initiation. However, Morris, Mason, and Hutchison
[25] have been unable to demonstrate any effect of CYS on
macrophages (or natural killer cells) in the rat. Animals given
CYS are known to have blocked T cell responses [10—12] and
thus rats treated with CYS, and given GN-inducing antibodies
might be expected not to have T cells demonstrable in their
glomeruli. The current experiments confirm this prediction and
further validate the monoclonal antibody immunofluorescence
techniques used to demonstrate glomerular T cells. The initial
heterologous phase of proteinuria seen on day 1 is induced by
neutrophils [26] and therefore unaffected by CYS treatment.
Passive injury induced within 24 hr of the injection of heterolog-
ous anti-GBM antibody to non-immune rats cannot involve
CMI, and as expected T cells could not be demonstrated in the
glomeruli of these animals. Blocking the late (macrophage-
associated) phase of proteinuria further confirms its depen-
dence on an active immune response although it does not
distinguish between B and T cell components because antibody
production, as well as T cell responses, were significantly
reduced.
As the injection of sheep globulin into pre-immunized animals
may induce serum sickness, control group 5 was included
where normal sheep globulin rather than sheep anti-rat GBM
globulin was injected. The lack of GN, glomerular T cells, or
macrophages excluded a role for immune complex deposition in
the development of the lesion. It also excluded the possibility of
nonspecific T cell accumulation as a result of immunization with
FCA.
A marked mononuclearcytosis and T lymphocytosis was
associated with the development of autologous anti-GBM GN.
A relatively greater increase in T helper cells occurred com-
pared to the non-helper subset which may be an important
factor in the T cell involvement in this disease. Although the
TH/Ts ratio in the blood increased to 1.42, the proportion of T
helper cells was almost twice as high in rat glomeruli developing
autologous disease at the same time. This indicates that the
appearance of T helper cells in glomeruli is not merely a passive
reflection of the lymphocytosis in the peripheral blood, but
represents a selective accumulation of T helper cells at the
inflammatory site and suggests a functional role for these cells
in the initiation of disease,
Rats immunized and injected with normal sheep globulin also
developed significant increases in their blood mononuclear cell
and T cell numbers, but this effect was not as marked as in the
rats with autologous disease. The difference presumably re-
flects the amplification of the response as a result of humoral
inflammatory mediators released in the animals consequent on
tissue localization of antigen and tissue inflammation. Although
there is a twofold difference in T helper cells in the blood (group
lA compared to group 5), the difference between these two
groups in the numbers of T helper cells in the glomeruli is
80-fold, further indicating the highly selective nature of ac-
cumulation of glomerular T helper cells. The increase in circu-
lating lymphocytes in group 5 did not result in a similar increase
in the glomerular (or interstitial) lymphocytes, again supporting
the view that blood lymphocytosis does not lead to passive
lymphocyte accumulation in the kidney.
Blocking the autologous disease with CYS produced sig-
nificant diminution of the mononuclearcytosis and T lympho-
cytosis, with T cell subset ratios which were the same as for
normal animals. Because CYS prevented the deposition of the
disease-initiating antibody, it was not unexpected that the
lymphocytosis observed after the commencement of inflamma-
tory tissue damage (as seen in group lA) was not seen in these
animals. Therefore, it appears that glomerular localization of
the antigen with subsequent tissue inflammation is necessary
for the greater increase in the number of circulating mono-
nuclear cells and T cells, and results in a preferential increase in
T helper cells within glomeruli.
The current studies show that macrophage accumulation in
experimental anti-GBM antibody-induced GN is preceded by T
cell accumulation. This strongly suggests the involvement of
CMI in the generation of macrophage accumulation and sub-
sequent injury and provides a link between the observations of
macrophage-induced injury [1] and the demonstration of
lymphocyte-associated mechanisms of glomerular macrophage
accumulation [7]. Further experiments using adoptive transfer
of T cells, T cell blockade with specific monoclonal antibody,
and demonstration of lymphokine production will establish
whether these lymphocytes contribute functionally to the de-
velopment of the renal injury.
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